Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor | Patent Publication Number 20220370441

US 20220370441 A1
Patent NumberUS 11590128 B2
Application Number17834709
Filled DateJun 7, 2022
Priority DateSep 7, 2012
Publication DateNov 24, 2022
Original AssigneeRoche
Abbvie Inc.
Current AssigneeRoche
Abbvie Inc.
Inventor/ApplicantsChristian Klein
Rod A. Humerickhouse
John F. Seymour
Wayne John Fairbrother
Andrew W. Roberts
Deepak Sampath
Sari L. Heitner Enschede
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.